Leveraging GLP-1 Receptor Agonist Options to Advance Glycemic and Extraglycemic Goals in Type 2 Diabetes: A ClinicalImpact Curriculum

In my practice, I choose the most effective treatment across the board to control blood sugar and reduce the risk for complications from renal, cardiovascular, and other common comorbidities.

Zachary T. Bloomgarden, MD, MACE Physicians: maximum of 0.4 AMA PRA Category 1 Credits™ Registered Nurses: 0.4 Nursing contact hours Released: March 2, 2020 Expired: No longer available for credit

When discussing GLP-1 receptor agonists for patients with type 2 diabetes, it is important to know which adverse events may occur and which are myths.

Martin J. Abrahamson, MD, FACP Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Released: September 1, 2020 Expired: No longer available for credit

For patients with T2D and cardiovascular disease, we are fortunate to have several GLP-1 receptor agonists with an indication for reducing the risk of major adverse cardiovascular events. Here’s my approach to choosing among them.

Anne Peters, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Released: June 8, 2020 Expired: No longer available for credit

Read which GLP-1 RA I favor for patients with type 2 diabetes who are overweight or obese.

Robert S. Zimmerman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Released: October 26, 2020 Expired: No longer available for credit

How I use an oral GLP-1RA in the clinic.

Richard E. Pratley, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Released: October 22, 2020 Expired: No longer available for credit